Sign in
Taking peoplePhase 4

Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority trial

Key facts

Who runs it
Stichting Radboud University Medical Center
Where
Netherlands10 sites in 1 countryChoose a country to see its sites
Status
Recruiting
Phase
Phase 4
People taking part
76 people, planned
Started
2 May 2024
Planned end
1 Jul 2025
Type of study
Interventional
Record updated
31 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Confirmed chronic pancreatitis
  • Abdominal pain typical for chronic pancreatitis (i.e. dull epigastric pain), NRS ≥ 3, ≥ 3 days/week for two weeks

Who cannot take part

  • Endoscopic or surgical intervention < 3 months prior to inclusion
  • Expected endoscopic or surgical intervention for CP within trial duration (6 weeks)
  • Start of amitriptyline, pregabalin or gabapentin less than 6 weeks prior to inclusion
  • Usage of more than 90 morphine milligram equivalents per day
  • Active use of metamizole at inclusion
  • Contra-indications to metamizole
  • Pancreatic carcinoma

This trial is currently available in Netherlands.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To study if adding metamizole three times daily at a dosage of 1000mg to the current analgesic therapy effectively reduce pain in patients with painful chronic pancreatitis, with time since diagnosis of less than 3 years

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled trial.
Record updated
31 March 2025